Maxi Investments CY Ltd Acquires 68,189 Shares of UiPath, Inc. (NYSE:PATH)

Key Points

• Maxi Investments CY Ltd increased its stake in UiPath, Inc. by 90.1%, owning a total of 143,889 shares worth approximately $1.48 million after purchasing additional shares in the 1st quarter.
• Insider trading activity includes CEO Daniel Dines selling 45,000 shares valued at $559,350, and CFO Ashim Gupta selling 56,322 shares for $716,416, contributing to a total insider sale of 831,310 shares worth over $10.4 million in the last 90 days.
• After recent performance, UiPath received a mix of ratings from analysts, including lowered expectations from Wall Street Zen and increased target prices from Royal Bank of Canada, with a current consensus rating of "Hold".

Maxi Investments CY Ltd increased its stake in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 90.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 143,889 shares of the company's stock after purchasing an additional 68,189 shares during the period. Maxi Investments CY Ltd's holdings in UiPath were worth $1,482,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in PATH. Senvest Management LLC lifted its holdings in UiPath by 29.2% during the fourth quarter. Senvest Management LLC now owns 14,074,783 shares of the company's stock worth $178,890,000 after acquiring an additional 3,180,300 shares in the last quarter. AQR Capital Management LLC lifted its holdings in UiPath by 45.3% during the fourth quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company's stock worth $84,209,000 after acquiring an additional 2,072,089 shares in the last quarter. Federated Hermes Inc. lifted its holdings in UiPath by 479.3% during the first quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company's stock worth $58,917,000 after acquiring an additional 4,732,712 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in UiPath by 35.6% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company's stock worth $69,385,000 after acquiring an additional 1,432,569 shares in the last quarter. Finally, Two Sigma Investments LP lifted its holdings in UiPath by 8.2% during the fourth quarter. Two Sigma Investments LP now owns 5,276,248 shares of the company's stock worth $67,061,000 after acquiring an additional 400,726 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

UiPath Stock Down 2.6%

Shares of UiPath stock traded down $0.28 on Friday, hitting $10.65. The stock had a trading volume of 9,073,690 shares, compared to its average volume of 14,424,310. UiPath, Inc. has a twelve month low of $9.38 and a twelve month high of $15.93. The business's 50 day moving average is $12.45 and its two-hundred day moving average is $12.30. The stock has a market cap of $5.70 billion, a price-to-earnings ratio of -88.74, a price-to-earnings-growth ratio of 14.32 and a beta of 1.03.

UiPath (NYSE:PATH - Get Free Report) last posted its earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.10 by $0.01. The company had revenue of $356.62 million for the quarter, compared to the consensus estimate of $332.17 million. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.13 earnings per share. As a group, equities analysts predict that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently commented on PATH shares. DA Davidson upgraded UiPath to a "hold" rating in a report on Tuesday, July 22nd. Wall Street Zen lowered UiPath from a "strong-buy" rating to a "buy" rating in a report on Sunday, August 3rd. Canaccord Genuity Group set a $16.00 price target on UiPath and gave the company a "buy" rating in a report on Monday, June 2nd. Truist Financial boosted their price target on UiPath from $12.00 to $13.00 and gave the company a "hold" rating in a report on Friday, May 30th. Finally, Barclays reaffirmed an "equal weight" rating on shares of UiPath in a research report on Friday, May 30th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $13.83.

Insider Activity

In related news, CEO Daniel Dines sold 9,988 shares of the business's stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $12.00, for a total value of $119,856.00. Following the completion of the sale, the chief executive officer directly owned 4,598,388 shares in the company, valued at approximately $55,180,656. The trade was a 0.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders sold 831,310 shares of company stock valued at $10,428,922 in the last three months. Insiders own 23.19% of the company's stock.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.